Table 1.
Participants demographics from the 3 testing sites.
Total | LTC 1 | LTC 2 | AC1 | |||||
---|---|---|---|---|---|---|---|---|
Sex | ||||||||
Female | 33 | 64.7% | 9 | 90% | 13 | 68% | 11 | 50% |
Male | 18 | 35.3% | 1 | 10% | 6 | 32% | 11 | 50% |
Age | ||||||||
Mean | 80 | 80 | 84 | 77 | ||||
Median | 84 | 89 | 86 | 75 | ||||
Range | 21–102 | 29–102 | 65–101 | 21–100 | ||||
Resident / HCW | ||||||||
Resident | 48 | 94.1% | 8 | 80% | 19 | 100% | 21 | 93% |
HCW | 3 | 5.9% | 2 | 20% | 0 | 0% | 1 | 7% |
Clinical presentation | ||||||||
Symptomatic | 25 | 49.0% | 10 | 100% | 0 | 0% | 15 | 68% |
Asymptomatic | 26 | 51.0% | 0 | 0% | 19 | 100% | 7 | 32% |